不确定的潜力和心血管疾病的克隆造血:一篇综述
Nagendra Boopathy Senguttuvan1, Vinodhini Subramanian2, Muralidharan Tr3
1Department of Cardiology, Sri Ramachandra Institute of Higher Education & Research (SRIHER), Chennai, India.
Indian heart journal
|January 25, 2025
概括
经常被忽视的克隆性血液形成 (CHIP) 突变与心血管疾病 (CVD) 有关. 准CHIP途径可能会降低心脏病患者的风险.
科学领域:
- 遗传学和心脏病学
- 血液学和心血管医学 血液学和心血管医学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 已确定的心血管疾病风险因素包括脂质不良,吸烟,糖尿病,高血压和肥胖.
- 越来越多地认识到其他疾病和心血管健康之间的重叠遗传联系.
研究的目的:
- 探索中间潜力的克隆性血液形成 (CHIP) 与心血管疾病 (CVD) 之间的关联.
- 突出针对CHIP途径减少残留心血管风险的潜力.
主要方法:
- 对确定导致CHIP的突变 (例如,TET2,DNMT3A,ASXL1,JAK2) 的研究进行审查.
- 对将CHIP突变与特定心血管疾病联系起来的流行病学数据的分析.
主要成果:
- 通过特定基因突变特征的CHIP与与年龄相关的血液状况有关.
- CHIP突变与冠状动脉疾病,心力衰竭,大动脉狭窄和心律失常的风险增加有关.
- 解决CHIP-CVD联系提供了一个减轻心血管风险的机会.
结论:
- CHIP和CVD之间的关联需要进一步调查.
- 针对炎症体,白内素通路或CHIP突变的治疗策略可能为心血管疾病管理提供新的方法.
相关概念视频
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Overview of Hematopoiesis
3.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.7K
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K


